Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,571 across all filing types
Latest filing 2023-08-09 Board/Management Inform…
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 7, 2023, reporting the departure of directors and officers and the appointment of a new Chief Technology Officer. The key section is Item 5.02, which specifically addresses changes in directors or certain officers. There is no financial data or report content, only an announcement of management changes. The document also includes a press release as an exhibit about these changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3572 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2023-08-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 9, 2023, reporting the results of operations and financial condition for the second quarter ended July 2, 2023. It includes a press release announcing financial results, which is typical of an Earnings Release. The document length is 3963 characters, which is relatively short and consistent with an earnings announcement rather than a full interim report. The text explicitly states that the press release announces financial results for the quarter, and the 8-K format is commonly used for earnings releases. Therefore, the document is best classified as an Earnings Release (ER).
2023-08-09 English
PRIMARY DOCUMENT
Director's Dealing
2023-07-27 English
Regulatory Filings 2023
Regulatory Filings
2023-07-24 English
8-K/A
Board/Management Information Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, which is an amendment to a current report. The content focuses on the appointment of an interim CEO and related compensation adjustments, which are changes in senior management. There are no financial statements or detailed financial performance data present. The document is about management changes and related disclosures, fitting the category of Board/Management Information (MANG). The document length is 4745 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is MANG with high confidence.
2023-07-18 English
PRIMARY DOCUMENT
Director's Dealing
2023-07-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.